Archive for October, 2008

Business Wire - Fitch Rates Abbott’s $4B Senior Notes ‘AA-’

Wednesday, October 29th, 2008

CHICAGO — Fitch has assigned an ‘AA-’ rating to Abbott Laboratories’ (Abbott) proposed public issuance of $4 billion of senior notes. The notes will be offered in three tranches with three-year, five-year, and 10-year terms. The Rating Outlook is Stable.
Abbott’s ratings are:
— Issuer Default Rating (IDR) ‘AA-’;
— Bank loan debt ‘AA-’;
— Senior unsecured debt ‘AA-’;
— Co…

Business Wire - Andrx Comments On Clarithromycin ER Preliminary Injunction

Thursday, October 23rd, 2008

FORT LAUDERDALE, Fla. — Andrx Corporation (Nasdaq: ADRX) (”Andrx” or “Company”) announced today that the U.S. District Court for the District of Northern Illinois granted Abbott Laboratories’ motion for a preliminary injunction related to Andrx’s generic Clarithromycin Extended Release Tablets pending a trial on the merits. The Company is evaluating the …

Business Wire - Fitch: Abbott Laboratories’ Ratings Unchanged After Acquisition Announcement

Monday, October 20th, 2008

CHICAGO — Fitch Ratings does not expect the ratings and Outlook for Abbott Laboratories (Abbott) to change in light of the company’s announcement of its intention to acquire Guidant’s (Guidant Corporation) vascular business for approximately $3.8 bi…

Why Give Up When Sinus Infection Antibiotics Can Rescue

Thursday, October 16th, 2008

For many years now,sinus infection antibiotics have been used to treat bacterial sinus infections without disappointing anyone. However,different antibiotics are usually used to treat different types of sinus bacterial infections that a person may …

News: The International Myeloma Foundation Says Study Shows 90% …

Sunday, October 12th, 2008

The International Myeloma Foundation (IMF) - supporting research
and providing education, advocacy and support for myeloma patients,
families, researchers and physicians - today said updated data from
the Phase II BiRD study provide a new option for newly diagnosed
patients with multiple myeloma whether or not they proceed to stem
cell transplant. The fin…

Journal of Family Practice - Switching antibiotics mid course improves H pylori cure rate

Monday, October 6th, 2008

* Clinical question
Is a sequential antibiotic treatment for Helicobacter pylori more effective than a continuous 10-day regimen?
* Bottom line
Yes. Response to H pylori eradication has dropped to approximately 80% because of antibiotic resistance. A regimen of pantoprazole (Protonix) 40 mg with amoxicillin 1 g twice daily for the first 5 days, followed by pantoprazole 40 mg, tinidazole (Tindamax) 500 mg, and clarithromycin (Biaxin) 500 mg, each administered twice da…

American Family Physician - Clarithromycin ineffective for coronary heart disease

Wednesday, October 1st, 2008

Clinical Question: In patients with stable coronary heart disease, does clarithromycin (Biaxin) treatment decrease bad outcomes?
Setting: Outpatient (any)
Study Design: Randomized controlled trial (double-blinded)
Allocation: Concealed

Most Popular
5 Regular Mistakes In Public Speaking
13 Job Interview Mistakes To Avoid
3 Questions No Job Seeker Ever Wants To Be Asked?
Public Speaking: 7 Secrets Of Great Public Speakers…